This Swanson Bacopa Monniera offers a very low-cost entry point into Bacopa supplementation but provides a dosage significantly below what is typically considered clinically effective, making its overall utility questionable for those seeking tangible results.
This Swanson Bacopa Monniera offers a very low-cost entry point into Bacopa supplementation but provides a dosage significantly below what is typically considered clinically effective, making its overall utility questionable for those seeking tangible results.
Bacopa Monniera is a well-regarded adaptogenic herb known for its potential benefits in cognitive function, memory enhancement, and stress reduction. This Swanson product provides 50mg of a 10:1 extract. While the 10:1 concentration ratio sounds promising for potency, the absolute quantity of the extract is quite low, especially without specifying the percentage of active bacosides. Many clinical trials demonstrating efficacy for Bacopa use dosages ranging from 150mg to 300mg of extracts standardized to 50% bacosides, or significantly higher amounts of non-standardized material. As such, this 50mg dose, even as a 10:1 extract, may be sub-therapeutic for many individuals seeking significant cognitive or stress-relief benefits, despite its attractive price point of $0.06 per serving. Online reviews often highlight the product's affordability, but some users may find its effects subtle or non-existent compared to more potent formulations recommended by nutritionists.
![]() | $ 0.00 | |
$ 5.99 |
Ingredient | Amount per serving |
---|---|
Bacopa monniera leaf 10:1 extract | 50 mg |